|
|
|
|
Molecular Pharmacology, Vol 3, 333-340, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Medicine and Physiology and Pharmacology, Duke University
Medical Center, Durham, North Carolina 27706
Intravenous administration of hypoglycin (L-
-amino-
-methylenecyclopropanepropionic acid) to mice resulted in hypoglycemia, which was preceded by a decrease in palmitate oxidation by myocardial homogenates from treated animals. The homogenates from
treated animals carried out normal rates of glucose and hexanoate oxidation, but demonstrated depressed levels of palmityl-CoA:carnitine acyltransferase activity. The addition
of carnitine to the myocardial homogenates restored both the depressed palmitate oxidation and palmityl-CoA:carnitine acyltransferase activity to normal levels. The administration of carnitine to hypoglycin-treated animals prevented the decreases in myocardial
palmitate oxidation, palmityl-CoA:carnitine acyltransferase activity, and the hypoglycemia.
Note:
ACKNOWLEDGMENT
We wish to thank Dr. H. Lebovitz for his help
and advice. Supported by U.S.P.H.S. Grants no.
HE 7061 and 5TIGM-516.